Skip to content

Prospective observational study for the safety and efficacy of chemotherapy in gastric cancer

Prospective observational study for the safety and efficacy of chemotherapy in gastric cancer - Prospective study for the chemotherapy in gastric cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000044817
Enrollment
150
Registered
2021-07-09
Start date
2021-07-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

None listed

Sponsors

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Inpatients and outpatients who were diagnosed gastric cancer and receive chemotherapy from the permission of ethics committee to March 31,2026. 2. Patients who can offer written informed consent 3. Patients with 20 years and over

Exclusion criteria

Exclusion criteria: 1. Patients who are not suitable for chemotherapy 2. Patients who reject chemotherapy

Design outcomes

Primary

MeasureTime frame
Overall survival (OS) and the contributing factors associated with OS

Countries

Japan

Contacts

Public ContactYoshiyasu Kono

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Gastroenterology and Hepatology

hxnwq178@yahoo.co.jp086-235-7219

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026